Digoxin Therapy in Acute Heart Failure

  • E. C. Rackow
  • M. I. Griffel
  • M. H. Weil
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 6)


The use of digitalis glycosides in the management of acute heart failure remains controversial [1–4]. In 1785, Withering [5] recognized that the narrow therapeutic-toxic dose ratio of cardiac glycosides dictated a firm understanding of the mechanisms of action and toxicities of these drugs on the part of physicians to ensure skillful clinical use. For purposes of this discussion, the term digitalis refers to all of the glycoside compounds that have both inotropic and electrophysiologic effects on the heart. Since the pharmacologic actions of these drugs are basically similar, they are considered as a group with special reference to a few of the cardiac glycosides in widespread clinical use.


Acute Myocardial Infarction Acute Myocardial Infarction Acute Heart Failure Pulmonary Artery Wedge Pressure Digitalis Glycoside 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Marcus FI (1980) Editorial: Use of digitalis in acute myocardial infarction. Circulation 62: 17–19PubMedGoogle Scholar
  2. 2.
    daLuz PL, Weil MH, Shubin H (1976) Current concepts on mechanisms and treatment of cardiogenic shock. Am Heart J 92: 103–113CrossRefGoogle Scholar
  3. 3.
    Genton R, Jaffe AS (1986) Management of congestive heart failure in patients with acute myocardial infarction. JAMA 256: 2556–2560PubMedCrossRefGoogle Scholar
  4. 4.
    Smith TW (1988) Digitalis–Mechanisms of action and clinical use. N Engl J Med 318: 358–365PubMedCrossRefGoogle Scholar
  5. 5.
    Withering W (1941) An account of the foxglove and some of its medical uses, with practical remarks on dropsy, and other diseases. In: Willius FA, Keys TE (eds) Cardiac Classics. Henry Schuman Inc, New York, p 231Google Scholar
  6. 6.
    Braunwald E, Sonneblick EM, Ross J (1988) Mechanisms of cardiac contraction and relaxation. In: Braunwald E (ed) Heart disease, 3rd edn. Saunders, Philadelphia, pp 383–394Google Scholar
  7. 7.
    Kim D, Marsh JD, Barry WH, Smith TW (1984) Effects of growth in low potassium medium or ouabain on membrane NA, K ATPase, cation transport, and contractility in cultured chick heart cells. Circ Res 55: 39–48Google Scholar
  8. 8.
    Eisner DA, Lederer WJ (1985) Na-Ca exchange: Stoichiometry and electrogenicity. Am J Physiol 248: C189 - C202PubMedGoogle Scholar
  9. 9.
    Barry WH, Hasin Y, Smith TW (1985) Sodium pump inhibition, enhanced calcium influx via sodium-calcium exchange, and positive inotropic response in cultured heart cells. Circ Res 56: 231–241PubMedGoogle Scholar
  10. 10.
    Gillis RA, Quest JA (1979) The role of the nervous system in the cardiovascular effects of digitalis. Pharmacol Rev 31: 19–97PubMedGoogle Scholar
  11. 11.
    Ross J, Braunwald E, Waldhausen JA (1960) Studies on digitalis II. Extracardiac effects on venous return and on the capacity of the peripheral vascular bed. J Clin Invest 39: 937–942Google Scholar
  12. 12.
    Ross J, Waldhausen JA, Braunwald E (1960) Studies on digitalis I. Direct effects on peripheral vascular resistance. J Clin Invest 39: 930–936Google Scholar
  13. 13.
    Mason D, Braunwald E (1984) Studies on digitalis X. Effects of ouabain on forearm vascular resistance and venous tone in normal subjects and in patients with heart failure. J Clin Invest 43: 532–543Google Scholar
  14. 14.
    Braunwald E, Bloodwell RD, Goldberg LI, Morrow AG (1960) Studies on digitalis IV. Observations in man on the effects of digitalis preparations on the contractility of the non-failing heart and on total vascular resistance. J Clin Invest 40: 52–59Google Scholar
  15. 15.
    DeMots H, Rahimtoola SH, McAnulty JH, Porter GA (1978) Effects of ouabain on coronary and systemic vascular resistance and myocardial oxygen consumption in patients without heart failure. Am J Cardiol 41: 88–93PubMedCrossRefGoogle Scholar
  16. 16.
    Braunwald E (1985) Effects of digitalis on the normal and the failing heart. J Am Coll Cardiol 5: 51A - 59APubMedCrossRefGoogle Scholar
  17. 17.
    Covell JW, Braunwald E, Ross J, Sonnenblick EH (1966) Studies on digitalis XVI. Effects on myocardial oxygen consumption. J Clin Invest 45: 1535–1542Google Scholar
  18. 18.
    Maroko PR, Kjekshus JK, Sobel BE, et al (1971) Factors influencing infarct size following experimental coronary artery occlusion. Circulation 43: 67–82PubMedGoogle Scholar
  19. 19.
    Watanabe T, Covell JW, Maroko PR, Braunwald E, Ross J (1972) Effects of increased arterial pressure and positive inotropic agents on the severity of myocardial ischemia in the acutely depressed heart. Am J Cardiol 30: 371–377PubMedCrossRefGoogle Scholar
  20. 20.
    DeMots H, Rahimtoola SH, Kremkau EL, Bennett W, Mahler D (1976) Effect of ouabain on myocardial oxygen supply and demand in patients with chronic coronary artery disease. J Clin Invest 58: 312–319PubMedCrossRefGoogle Scholar
  21. 21.
    Morrison J, Coromilas J, Robbins M, et al (1980) Digitalis and myocardial infarction in man. Circulation 62: 8–16PubMedGoogle Scholar
  22. 22.
    Cronin RFP, Zsoter T (1965) Hemodynamic effects of rapid digitalization in experimental cardiogenic shock. Am Heart J 69: 233–240PubMedCrossRefGoogle Scholar
  23. 23.
    Marano M, Kline HJ, Cestero J, Kuhn LA (1966) Hemodynamic effects of ouabain in experimental acute myocardial infarction with shock. Am J Cardiol 17: 327–331PubMedCrossRefGoogle Scholar
  24. 24.
    Nola GT, Pope SE, Harrison DL (1972) Action of acetylstrophanthidin on experimental myocardial infarction. Am J Physiol 222: 265–271PubMedGoogle Scholar
  25. 25.
    Rackow EC, Packman MI, Weil MH (1987) Hemodynamic effects of digoxin during acute cardiac failure: A comparison in patients with and without acute myocardial infarction. Crit Care Med 15: 1001–1005Google Scholar
  26. 26.
    Rahimtoola SH, Sinno MZ, Chuquimia R, Loeb HS, Rosen KM, Gunnar RM (1972) Effects of ouabain on impaired left ventricular function in acute myocardial infarction. N Engl J Med 287: 527–531PubMedCrossRefGoogle Scholar
  27. 27.
    Lipp H, Denes P, Gambetta M, Resnekov L (1973) Hemodynamic response to acute intravenous digoxin in patients with recent myocardial infarction and coronary insufficiency with and without heart failure. Chest 63: 862–867PubMedCrossRefGoogle Scholar
  28. 28.
    Gander MP, Kazamias TM, Henry P, Ross J (1970) Serial determinations of cardiac output and response to digitalis in patients with acute myocardial infarction. Circulation 42: 155Google Scholar
  29. 29.
    Marchionni N, Pini R, Vannucci A, et al (1985) Hemodynamic effects of digoxin in acute myocardial infarction in man: A randomized controlled trial. Am Heart J 109: 63–69PubMedCrossRefGoogle Scholar
  30. 30.
    Ratshin RA, Rackley CE, Russell R (1972) Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction. Circulation 45: 127–139PubMedGoogle Scholar
  31. 31.
    Hodges M, Freisinger GC, Riggins RCK, Dagenais GR (1972) Effects of intravenously administered digoxin on mild left ventricular failure in acute myocardial infarction in man. Am J Cardiol 29: 749–756PubMedCrossRefGoogle Scholar
  32. 32.
    Meijler FL (1985) An account of digitalis and atrial fibrillation. J Am Coll Cardiol 5: 60A - 68APubMedCrossRefGoogle Scholar
  33. 33.
    Weiner P, Bassan MM, Jarchovsky J, Iusim S, Plavnick L (1983) Clinical course of acute atrial fibillation treated with rapid digitalization. Am Heart J 105: 223–227PubMedCrossRefGoogle Scholar
  34. 34.
    Jelliffe RW, Brooker G (1974) A monogram for digoxin therapy. Am J Med 57: 63–68PubMedCrossRefGoogle Scholar
  35. 35.
    Marcus FI (1985) Pharmacokinetic interactions between digoxin and other drugs. J Am Coll Cardiol 5: 82A - 90APubMedCrossRefGoogle Scholar
  36. 36.
    Bigger TJ (1979) The quinidine-digoxin interaction. N Engl J Med 301: 779–781PubMedCrossRefGoogle Scholar
  37. 37.
    Gustafsson K, Jogestrand T, Nordlander R, Dahlquist R (1981) Effect of quinidine on digoxin concentration in skeletal muscle and serum in patients with atrial fibrillation. N Engl J Med 305: 209–211CrossRefGoogle Scholar
  38. 38.
    Leahey EB, Reicffe JA, Heissenbuttel RH, Drusin RE, Lovejoy WP, Bigger JT (1979) Enhanced cardiac effect of digoxin during quinidine treatment. Arch Intern Med 139: 519–521PubMedCrossRefGoogle Scholar
  39. 39.
    Kumar R, Hood WB, Joison J, Gilmour DP, Norman JC, Abelman WH (1970) Efficacy and toxicity of digitalis in acute and healing phase in intact conscious dogs. J Clin Invest 49: 358–364PubMedCrossRefGoogle Scholar
  40. 40.
    Lown B, Klein MD, Barr I, Hagemeijer F, Kowosky BD, Garrison H (1972) Sensitivity to digitalis drugs in acute myocardial infarction. Am J Cardiol 30: 388–395PubMedCrossRefGoogle Scholar
  41. 41.
    Bigger JT, Fleiss JL, Rolnitsky LM, Merab JP, Ferrick KJ (1985) Effect of digitalis treatment on survival after acute myocardial infarction. Am J Cardiol 55: 623–630PubMedCrossRefGoogle Scholar
  42. 42.
    Ryan TJ, Bailey KR, McCabe CN, et al (1983) The effects of digitalis on survival in high risk patients with coronary artery disease. Circulation 67: 735–742PubMedCrossRefGoogle Scholar
  43. 43.
    Madsen EB, Gilpin E, Henning H, et al (1984) Prognostic importance of digitalis after acute myocardial infarction. J Am Coll Cardiol 3: 681–689PubMedCrossRefGoogle Scholar
  44. 44.
    Byington R, Goldstein S (1985) Association of digitalis therapy with mortality in survivors of acute myocardial infarction: Observations in the beta-blocker heart attack trial. J Am Coll Cardiol 6: 976–982Google Scholar
  45. 45.
    Muller JE, Turi ZG, Stone PH, et al (1986) Digoxin therapy and mortality after myocardial infarction: Experience in the MILIS study. N Engl J Med 314: 265–271PubMedCrossRefGoogle Scholar
  46. 46.
    Barr I, Smith TW, Klein MD, Hagemeijer F, Lown B (1972) Correlation of the electrophysiologic action of digoxin with serum digoxin concentration. J Pharmacol Exp Ther 180: 710–722PubMedGoogle Scholar
  47. 47.
    Lely AH, vanEnter CHJ (1972) Non-cardiac symptoms of digitalis intoxication (editorial). Am Heart J 83: 149–152PubMedCrossRefGoogle Scholar
  48. 48.
    Selzer A (1985) Role of serum digoxin assay in patient management. J Am Coll Cardiol 5: 106A - 110APubMedCrossRefGoogle Scholar
  49. 49.
    Rosen MR (1985) Cellular electrophysiology of digitalis toxicity. J Am Coll Cardiol 5: 22A - 34APubMedCrossRefGoogle Scholar
  50. 50.
    Fisch C, Knoebel SB (1985) Digitalis cardiotoxicity. J Am Coll Cardiol 5: 91A - 98APubMedCrossRefGoogle Scholar
  51. 51.
    Rosen MR, Wit AL, Hoffman BF (1975) Electrophysiology and pharmacology of cardiac arrhythmias IV Cardiac antiarrhythmic and toxic effects of digitalis. Am Heart J 89: 391–399PubMedCrossRefGoogle Scholar
  52. 52.
    Henderson RP, Solomon CP (1988) Use of cholestyramine in the treatment of digoxin intoxication. Arch Intern Med 148: 745–746PubMedCrossRefGoogle Scholar
  53. 53.
    Haber E (1985) Antibodies and digitalis: The modern revolution in the use of an ancient drug. J Am Coll Cardiol 5: 111A - 117APubMedCrossRefGoogle Scholar
  54. 54.
    Wenger TL, Butler VP, Haber E, Smith TW (1985) Treatment of 63 severely digitalis-toxic patients with digoxin-specific antibody fragments. J Am Coll Cardiol 5: 118A - 123APubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • E. C. Rackow
  • M. I. Griffel
  • M. H. Weil

There are no affiliations available

Personalised recommendations